TUMOUR NECROSIS FACTOR INHIBITORS PERSISTENCE IN PSORIATIC ARTHRITIS PATIENTS

被引：0

作者：

Vieira-Sousa, E. ^{[1
,2
]}

Eusebio, M. ^{[3
]}

Avila-Ribeiro, P. ^{[1
,2
]}

Khmelinskii, N. ^{[1
,2
]}

Machado, A. R. ^{[1
,2
]}

Martins Rocha, T. ^{[4
,5
]}

Bernardes, M. ^{[4
,5
]}

Santos-Faria, D. ^{[6
]}

Leite Silva, J. ^{[6
]}

Santos, H. ^{[7
]}

Miguel, C. ^{[7
]}

Carvalho, P. ^{[8
]}

Costa, T. ^{[9
]}

Teixeira, L. ^{[10
]}

Meirinhos, T. ^{[11
]}

Nero, P. ^{[12
]}

Santos, M. J. ^{[10
]}

机构：

[1] Univ Lisbon, Lisbon Acad Med Ctr, Hosp Santa Maria, CHLN,Rheumatol & Metab Bone Dis Dept, Lisbon, Portugal

[2] Univ Lisbon, Lisbon Acad Med Ctr, Inst Med Mol, Fac Med,Rheumatol Res Unit, Lisbon, Portugal

[3] Portuguese Soc Reumatol, Lisbon, Portugal

[4] Univ Porto, Ctr Hosp Sao Joao Porto, Rheumatol Dept, Porto, Portugal

[5] Univ Porto, Fac Med, Porto, Portugal

[6] Unidade Local Saude Alto Minho, Rheumatol Dept, Ponte do Lima, Portugal

[7] Inst Portugues Reumatol, Lisbon, Portugal

[8] Hosp Univ Coimbra, Rheumatol Dept, Coimbra, Portugal

[9] Hosp Egas Moniz, CHLO, Rheumatol Dept, Lisbon, Portugal

[10] Hosp Garcia Orta, Rheumatol Dept, Almada, Portugal

[11] Ctr Hosp Baixo Vouga, Rheumatol Dept, Aveiro, Portugal

[12] Hosp CUF Descobertas, Lisbon, Portugal

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2018年 / 77卷

关键词：

D O I：

10.1136/annrheumdis-2018-eular.5998

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0920

引用

页码：1584 / 1585

页数：2

共 50 条

[1] TUMOR NECROSIS FACTOR INHIBITORS PERSISTENCE IN PSORIATIC ARTHRITIS PATIENTS
Vieira-Sousa, E.
Eusebio, M.
Avila-Ribeiro, P.
Khmelinskii, N.
Machado, A. R.
Martins-Rocha, T.
Bernardes, M.
Santos-Faria, D.
Leite Silva, J.
Santos, H.
Miguel, C.
Carvalho, P.
Costa, T.
Teixeira, L.
Meirinhos, T.
Nero, P.
Santos, M. J.
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (04) : 731 - 732
[2] Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritis
Stober, Carmel
Ye, Weiyu
Guruparan, Thushyanthan
Htut, Eiphyu
Clunie, Gavin
Jadon, Deepak
[J]. RHEUMATOLOGY, 2018, 57 (01) : 158 - 163
[3] TUMOUR NECROSIS FACTOR INHIBITORS AND THEIR IMPACT ON DIABETES MELLITUS AMONG PATIENTS WITH PSORIATIC ARTHRITIS
Mantravadi, S.
George, M.
Ogdie, A.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1599 - 1599
[4] Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors
Mease, PJ
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (04) : 298 - 304
[5] THE PSABio STUDY IN ITALY: A REAL-WORLD COMPARISON OF THE PERSISTENCE, EFFECTIVENESS AND SAFETY OF USTEKINUMAB AND TUMOUR NECROSIS FACTOR INHIBITORS IN PATIENTS WITH PSORIATIC ARTHRITIS
Gremese, E.
Ciccia, F.
Selmi, C.
Cuomo, G.
Foti, R.
Cerinic, M. Matucci
Conti, F.
Fusaro, E.
Guggino, G.
Iannone, F.
Delle Sedie, A.
Perricone, R.
Idolazzi, L.
Moscato, P.
Theander, E.
Noel, W.
Bergmans, P.
Marelli, S.
Gossec, L.
Smolen, J. S.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 778 - 779
[6] Gender Differences in Psoriatic Arthritis - Impact on Tumor Necrosis Factor Inhibitors Persistence and Response
Vieira-Sousa, Elsa
Eusebio, Monica
Avila-Ribeiro, Pedro
Khmelinskii, Nikita
Cruz-Machado, Rita
Rocha, Teresa Martins
Bernardes, Miguel
Santos-Faria, Daniela
Silva, Joana Leite
Santos, Helena
Miguel, Claudia
Carvalho, Pedro
Costa, Tiago
Teixeira, Lidia
Meirinhos, Tiago
Nero, Patricia
Fonseca, Joao Eurico
Santos, Maria Jose
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[7] GENDER DIFFERENCES IN PSORIATIC ARTHRITIS IMPACT ON TUMOR NECROSIS FACTOR INHIBITORS PERSISTENCE AND RESPONSE
Vieira-Sousa, Elsa
Eusebio, Monica
Avila-Ribeiro, Pedro
Khmelinskii, Nikita
Cruz-Machado, Ana Rita
Martins-Rocha, Teresa
Bernardes, Miguel
Faria, Daniela
Silva, Joana
Santos, Helena
Miguel, Claudia
Carvalho, Pedro
Costa, Tiago
Teixeira, Lidia
Meirinhos, Tiago
Nero, Patricia
Fonseca, Joao Eurico
Santos, Maria Jose
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1264 - 1265
[8] Tumor necrosis factor inhibitors in psoriatic arthritis
Mantravadi, Santhi
Ogdie, Alexis
Kraft, Walter K.
[J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (08) : 899 - 910
[9] Comparative Persistence of Methotrexate and Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
George, Michael D.
Baker, Joshua F.
Ogdie, Alexis
[J]. JOURNAL OF RHEUMATOLOGY, 2020, 47 (06) : 826 - 834
[10] Bone anabolic changes progress in psoriatic arthritis patients despite treatment with methotrexate or tumour necrosis factor inhibitors
Finzel, Stephanie
Kraus, Sebastian
Schmidt, Sarah
Hueber, Axel
Rech, Juergen
Engelke, Klaus
Englbrecht, Matthias
Schett, Georg
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (07) : 1176 - 1181

← 1 2 3 4 5 →